Depression remains one of the most prevalent and challenging health conditions worldwide. Despite substantial advances in psychological, psychiatric, and pharmacological treatment, many individuals continue to experience persistent symptoms or treatment-resistant depression despite receiving otherwise appropriate care. This raises an important question: are there upstream biological factors influencing symptom development, persistence, and treatment responsiveness that current models do not fully explain? This paper explores that question through the framework of Distemperantia Allostatica Onerosus (DAO), a recently published framework describing the progressive impairment of adaptive psychophysiological regulation under sustained allostatic burden. DAO proposes that chronic dysregulation across autonomic, endocrine, circadian, respiratory, and neurophysiological systems may reduce the organism's capacity to recover, adapt, and respond effectively to physiological, psychological, and therapeutic demands. Building upon the published DAO framework, this paper advances a specific hypothesis: that DAO-type regulatory impairment may contribute to a subset of depressive presentations and may help explain some cases of treatment-resistant depression. Within this framework, depression is examined as one possible downstream clinical expression of impaired adaptive regulation, while treatment resistance is considered a potential failure of intervention responsiveness occurring within a dysregulated biological system. Particular attention is given to athletic populations, where repeated head impacts, concussion, disrupted recovery dynamics, autonomic dysregulation, elevated allostatic burden, and mood disturbance frequently coexist. The framework further raises the possibility that some post-concussive depressive presentations may be understood not solely through traditional psychiatric or psychological models, but also as downstream manifestations of impaired adaptive regulation. If correct, this would provide a biologically plausible bridge between concussion, autonomic dysregulation, recovery failure, and depression, particularly in athletic populations exposed to repeated head impacts. The DAO hypothesis is further informed by clinical observations in post-concussive populations, where regulatory dysfunction and depressive symptomatology have frequently coexisted. Across these observations, improvements in adaptive regulation have often been accompanied by reductions in patient-reported depressive symptoms and improvements in recovery trajectories. While these findings are observational and cannot establish causation, they raise the possibility that impaired adaptive regulation may contribute to certain post-concussive depressive presentations and warrant formal investigation. This is a hypothesis and position paper, not a report of clinical outcomes. DAO remains a proposed framework requiring prospective validation, independent replication, and rigorous empirical testing. No primary outcome data are presented. Instead, the paper outlines biologically plausible mechanisms, testable predictions, and research directions designed to determine whether adaptive regulatory capacity influences the development, persistence, or treatment responsiveness of depression. At its core, this paper asks a simple but important question: for some individuals, could restoring regulatory capacity be a prerequisite for recovery?
Tiffanny Holbrook (Tue,) studied this question.